1. Home
  2. ENHA vs FDMT Comparison

ENHA vs FDMT Comparison

Compare ENHA & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enhanced Group Inc. Class A Common Stock

ENHA

Enhanced Group Inc. Class A Common Stock

N/A

Current Price

$1.49

Market Cap

632.1M

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

BUY

Current Price

$12.57

Market Cap

695.3M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ENHA
FDMT
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
632.1M
695.3M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
ENHA
FDMT
Price
$1.49
$12.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$4.00
★ $28.18
AVG Volume (30 Days)
821.4K
★ 909.8K
Earning Date
11-13-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.79
EPS
★ N/A
N/A
Revenue
N/A
★ $85,209,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$168.06
$56.84
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 230194.60
52 Week Low
$1.37
$6.96
52 Week High
$4.60
$16.93

Technical Indicators

Market Signals
Indicator
ENHA
FDMT
Relative Strength Index (RSI) 42.34 36.78
Support Level N/A $8.68
Resistance Level $1.66 $14.00
Average True Range (ATR) 0.10 0.95
MACD 0.03 -0.29
Stochastic Oscillator 44.63 6.87

Price Performance

Historical Comparison
ENHA
FDMT

About ENHA Enhanced Group Inc. Class A Common Stock

Enhanced Group Inc develops and sells sports and performance-related products intended for use by athletes and consumers. Its offerings focus on products associated with physical performance, health, and recovery. Its two principal offerings include: (i) the Enhanced Games, a live, multi-sport competition platform designed to showcase both "Enhanced" and "Non-Enhanced" athletes pursuing world-record performances under medically supervised conditions; and (ii) Live Enhanced, a direct-to-consumer digital and clinician-guided wellness platform offering evidence-based protocols, supplements, and coaching for consumers seeking to improve health, longevity, and well-being. The majority of the company's revenue is derived from products associated with physical performance, health, and recovery.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: